Detection of the MYD88 p.L265P Mutation in the CSF of a Patient With Secondary Central Nervous System Lymphoma

by Soheil Zorofchian, Guangrong Lu, Jay-Jiguang Zhu, Dzifa Y. Duose, Justin Windham, Yoshua Esquenazi, Leomar Y. Ballester, Leomar Y. Ballester
Published 2018-09-01

Primary Leptomeningeal Oligodendroglioma, IDH-Mutant, 1p/19q-Codeleted

by Leomar Y. Ballester, Leomar Y. Ballester, Erin Dunbar, Nandita Guha-Thakurta, John W. Henson, Howard Chandler, Jeremiah Watkins, Gregory N. Fuller
Published 2018-08-01

Coexisting FGFR3 p.K650T mutation in two FGFR3-TACC3 fusion glioma cases

by Leomar Y. Ballester, Soheil Zorofchian Moghadamtousi, Norman E. Leeds, Jason T. Huse, Gregory N. Fuller
Published 2019-04-01

Assessment of Glioblastoma Response in the Era of Bevacizumab: Longstanding and Emergent Challenges in the Imaging Evaluation of Pseudoresponse

by Octavio D. Arevalo, Carolina Soto, Pejman Rabiei, Arash Kamali, Leomar Y. Ballester, Yoshua Esquenazi, Jay-Jiguang Zhu, Roy Francisco Riascos
Published 2019-05-01

Suppression of HMGB1 Released in the Glioblastoma Tumor Microenvironment Reduces Tumoral Edema

by Bangxing Hong, Kamaldeen Muili, Chelsea Bolyard, Luke Russell, Tae Jin Lee, Yeshavanth Banasavadi-Siddegowda, Ji Young Yoo, Yuanqing Yan, Leomar Y. Ballester, Kurt H. Bockhorst, Balveen Kaur
Published 2019-03-01

Analysis of cerebrospinal fluid metabolites in patients with primary or metastatic central nervous system tumors

by Leomar Y. Ballester, Guangrong Lu, Soheil Zorofchian, Venkatrao Vantaku, Vasanta Putluri, Yuanqing Yan, Octavio Arevalo, Ping Zhu, Roy F. Riascos, Arun Sreekumar, Yoshua Esquenazi, Nagireddy Putluri, Jay-Jiguang Zhu
Published 2018-08-01

Immunohistochemical and Molecular Features of Melanomas Exhibiting Intratumor and Intertumor Histomorphologic Heterogeneity

by Haider A. Mejbel, Sri Krishna C. Arudra, Dinesh Pradhan, Carlos A. Torres-Cabala, Priyadharsini Nagarajan, Michael T. Tetzlaff, Jonathan L. Curry, Doina Ivan, Dzifa Y. Duose, Raja Luthra, Victor G. Prieto, Leomar Y. Ballester, Phyu P. Aung
Published 2019-11-01

Efficacy and tolerability of anti-programmed death-ligand 1 (PD-L1) antibody (Avelumab) treatment in advanced thymoma

by Arun Rajan, Christopher R. Heery, Anish Thomas, Andrew L. Mammen, Susan Perry, Geraldine O’Sullivan Coyne, Udayan Guha, Arlene Berman, Eva Szabo, Ravi A. Madan, Leomar Y. Ballester, Stefania Pittaluga, Renee N. Donahue, Yo-Ting Tsai, Lauren M. Lepone, Kevin Chin, Fiona Ginty, Anup Sood, Stephen M. Hewitt, Jeffrey Schlom, Raffit Hassan, James L. Gulley
Published 2019-10-01